SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2018.08.008
Abstract: OBJECTIVE Paclitaxel, a microtubule inhibitor, is subject to tumor resistance while treating high-grade serous ovarian and uterine cancer. This study aims to directly compare the effects of SQ1274, a novel microtubule inhibitor that binds to… read more here.
Keywords: uterine cancer; cancer cell; cancer; ovarian uterine ... See more keywords